Daily non-political popular news in brief.

Model found to determine cause, possible treatment of nerve tumors

A multi-institutional study led by Cincinnati Children's Hospital Medical Center has led to new insights and a model to help unravel the cause of fibrous, noncancerous nerve tumors called neurofibromas, which can lead to disfigurement and in rare cases death by compressing vital organs. Writing for the February Cancer Cell, researchers said their findings also provide a way to test therapies that could eventually help patients with limited options for treating the disease -- Neurofibromatosis type 1.

Read more »

Keywords: model, determine, cause, possible, treatment, nerve, tumors, tumor

« Previous | Next »

Similar news on "Model found to determine cause, possible treatment of nerve tumors":

1. Therapeutic unshackles p53 and causes tumor regression
   03-15-2007 · EurekAlert!
   Infection with Kaposi's sarcoma virus (KSHV) can cause 3 types of tumor, including primary effusion lymphoma (PEL). Although KSHV has been known to cause tumors for many years, there are no effective therapies for KSHV-induced tumors. In a new study it is shown that the small-molecule inhibitor Nutlin-3a has antitumor effects in a mouse xenograft model of PEL, indicating that it might provide a viable therapeutic option for the treatment of individuals with PEL.
   Similar news · Read more »
   
2. Model for predicting survival in liver patients has many applications but could be refined further
   03-01-2007 · EurekAlert!
   A review of the studies on the Model for End-Stage Liver Disease (MELD) found that it is an accurate predictor of survival of patients with a variety of liver diseases, is particularly useful in allocating organs for liver transplants, and can also be used to help determine the course of treatment in certain cases. However, it is possible to improve the accuracy of the model and efforts at refining will continue.
   Similar news · Read more »
   
3. Treatment capitalizes on unique qualities of radioisotope to prolong lives of brain tumor patients
   01-30-2008 · EurekAlert!
   In a study to determine safe dosages of the isotope astatine-211 for patients with recurring brain tumors, researchers were pleasantly surprised to find that not only was the isotope's potency sufficient to kill residual cancer cells without damaging sensitive healthy brain cells, but the patients experienced longer survival rates.
   Similar news · Read more »
   
4. Jefferson scientists see breast cancer gene activity from outside the body
   11-28-2007 · EurekAlert!
   Researchers at Jefferson Medical College and Jefferson's Kimmel Cancer Center in Philadelphia have used PET imaging to see hyperactive cancer genes inside breast tumors in laboratory animals, marking the first time such gene activity has been observed from outside the body. This technology might someday help physicians to detect and classify cancer, enabling them to find cancerous breast tumors as early as possible, and determine the appropriate treatment.
   Similar news · Read more »
   
5. Therapeutic peptide frees the protein p73 to kill tumor cells
   03-08-2007 · EurekAlert!
   p53 suppresses tumor development by inducing tumor cell death. However, targeting p53 for the treatment of cancer is confounded by the fact that genetic mutations cause loss or inactivation of p53 in approximately 50 percent of human cancers. Now, a new study indicates that targeting the p53-related protein p73 in mice induces the regression of established tumors of human origin, leading to the suggestion that p73 might be a viable target for developing anticancer therapeutics.
   Similar news · Read more »
   
6. 2 microRNAs promote spread of tumor cells
   01-28-2008 · EurekAlert!
   Scientists at The Wistar Institute and their colleagues have identified two microRNAs that promote tumors' deadly spread. One of the miRNAs may provide an early warning of metastatic breast cancer and the need for aggressive treatment. In a study to be published Feb. 1 in Nature Cell Biology that is available online, the researchers describe how two miRNAs transformed non-invasive human breast cancer cells into cells that rapidly metastasized in cell cultures and mice.
   Similar news · Read more »
   
7. Reactivated gene shrinks tumors, MIT study finds
   01-24-2007 · Massachusetts Institute of Technology (MIT)
   Many cancers arise due to defects in genes that normally suppress tumor growth. Now, for the first time, MIT researchers have shown that re-activating one of those genes in mice can cause tumors to shrink or disappear.
   Similar news · Read more »
   
8. Gene expression test reveals ER and HER-2 status of breast tumors
   02-14-2007 · EurekAlert!
   Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online.
   Similar news · Read more »
   
9. Transplant drug sirolimus shrinks tumors, improves lung function
   01-09-2008 · EurekAlert!
   The drug sirolimus, normally used to help transplant patients fight organ rejection, may eventually be used as a less invasive treatment for a tumor called angiomyolipomata in patients with tuberous sclerosis complex or lymphangioleiomyomatosis who would otherwise face surgery. The finding is reported by investigators from Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine in the Jan. 10 edition of the New England Journal of Medicine.
   Similar news · Read more »
   
10. Gene malfunctions cause schizophrenia, depression symptoms in mice
    05-02-2007 · EurekAlert!
    Researchers have demonstrated for the first time that malfunction of a gene that had been associated with schizophrenia and depression does indeed cause symptoms of those disorders. They said their findings in mice offer a possible animal model for developing treatments for schizophrenia and depression.
    Similar news · Read more »